Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Empower Clinics Inc C.CBDT


Primary Symbol: EPWCF

Empower Clinics Inc. is a Canada-based integrated healthcare and medical device company with multi-disciplinary clinics. The Company provides body and mind wellness for patients through its medical clinics, digital and telemedicine care, medical diagnostics laboratories, and sale of medical devices. Its segments include Health & Wellness, comprising clinic operations, patient visits, and telemedicine services; Diagnostics & Technology, comprising the diagnostic testing services provided by Kai Medical, and the sale of medical equipment by Kai Medical Canada Corp. and MediSure; and Corporate. It is focused on offering clinical trial services, such as clinical trial design, patient recruitment, data management and regulatory compliance for the pharmaceutical, biotechnology and medical device industries. It has two clinical research sites in Dallas, Texas, becoming a site management organization (SMO) with six principal investigators (PI) with multiple clinical trials under application.


GREY:EPWCF - Post by User

Comment by Guguuchichion Feb 16, 2021 5:22pm
377 Views
Post# 32579981

RE:Congrats

RE:CongratsI believe that CBDT is following in the footsteps of WELL in terms of growth. However, where CBDT will excel is their growth via the Rexall deal will allow it to grow organically unliike WELL where it had grown due to acquistions and paying a price premium for the companies they acquired. The KAI testing will bring immediate surge in revenues to CBDT untill sufficient amount of Rexall clinics are consutructed and operating that will then be the mainstay of revenues - IMHO.
<< Previous
Bullboard Posts
Next >>